Understanding the impact of age-related changes in pediatric GI solubility by multivariate data analysis

Mariana Guimarães, Anil Maharaj, Andrea Edginton, Maria Vertzoni, Nikoletta Fotaki

Research output: Contribution to journalArticlepeer-review

1 Citation (SciVal)

Abstract

The aim of this study was to understand drug solubilization as a function of age and identify drugs at risk of altered drug solubility in newborns and young infants in comparison to adults. Multivariate statistical analysis was used to understand drug solubilization as a function of drug’s physicochemical properties and the composition of gastrointestinal fluids. The solubility of seven poorly soluble compounds was assessed in adult and age-specific fasted and fed state biorelevant media. Partial least squares regression (PLS-R) was used to assess the influence of (i) drug physicochemical properties and (ii) age-related changes in simulated GI fluids, as well as (iii) their interactions, on the pediatrics-to-adult solubility ratio (Sp/Sa (%)). For five out of seven of the compounds investigated, Sp/Sa (%) values fell outside of the 80–125% limits in at least one of the pediatric media. Lipophilicity was responsible for driving drug solubility differences between adults and children in all the biorelevant media investigated, while drug ionization was most relevant in the fed gastric media, and the fasted/fed intestinal media. The concentration of bile salts and lecithin in the fasted and fed intestinal media was critical in influencing drug solubility, while food composition (i.e., cow’s milk formula vs. soy formula) was a critical parameter in the fed gastric state. Changes in GI fluid composition between younger pediatric patients and adults can significantly alter drug luminal solubility. The use of pediatric biorelevant media can be helpful to identify the risk of altered drug solubilization in younger patients during drug development.
Original languageEnglish
Article number356
JournalPharmaceutics
Volume14
Issue number2
DOIs
Publication statusPublished - 4 Feb 2022

Bibliographical note

Funding Information:
Funding: This work has received funding from Horizon 2020 Marie Sklodowska-Curie Innovative Training Networks program under grant agreement No. 674909.

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Biopharmaceutics
  • Biorelevant
  • Multivariate analysis
  • Pediatric
  • Solubility

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Understanding the impact of age-related changes in pediatric GI solubility by multivariate data analysis'. Together they form a unique fingerprint.

Cite this